Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 19 studies | 32% ± 13% | |
smooth muscle cell | 9 studies | 29% ± 9% | |
fibroblast | 3 studies | 36% ± 13% |
Insufficient scRNA-seq data for expression of HEYL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 5910.93 | 328 / 328 | 97% | 51.06 | 172 / 178 |
prostate | 98% | 3235.90 | 240 / 245 | 96% | 22.17 | 483 / 502 |
lung | 100% | 4312.93 | 577 / 578 | 92% | 17.63 | 1058 / 1155 |
thymus | 98% | 3955.73 | 640 / 653 | 88% | 16.98 | 531 / 605 |
adrenal gland | 92% | 2137.57 | 237 / 258 | 92% | 44.42 | 212 / 230 |
breast | 84% | 1642.51 | 385 / 459 | 91% | 17.95 | 1022 / 1118 |
bladder | 86% | 1494.38 | 18 / 21 | 76% | 10.97 | 385 / 504 |
kidney | 76% | 1519.39 | 68 / 89 | 80% | 48.69 | 719 / 901 |
uterus | 98% | 4137.88 | 167 / 170 | 57% | 11.40 | 262 / 459 |
intestine | 65% | 999.51 | 626 / 966 | 82% | 14.58 | 433 / 527 |
ovary | 72% | 2173.26 | 129 / 180 | 70% | 9.30 | 303 / 430 |
esophagus | 49% | 721.88 | 704 / 1445 | 87% | 15.98 | 159 / 183 |
stomach | 45% | 688.62 | 163 / 359 | 88% | 22.81 | 252 / 286 |
brain | 45% | 592.17 | 1196 / 2642 | 80% | 13.50 | 566 / 705 |
blood vessel | 100% | 10360.90 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 5799.33 | 856 / 861 | 0% | 0 | 0 / 0 |
adipose | 93% | 2346.31 | 1116 / 1204 | 0% | 0 | 0 / 0 |
spleen | 83% | 1044.99 | 199 / 241 | 0% | 0 | 0 / 0 |
skin | 16% | 156.42 | 286 / 1809 | 60% | 16.45 | 282 / 472 |
liver | 13% | 160.50 | 30 / 226 | 59% | 12.23 | 241 / 406 |
tonsil | 0% | 0 | 0 / 0 | 49% | 5.15 | 22 / 45 |
eye | 0% | 0 | 0 / 0 | 40% | 4.06 | 32 / 80 |
muscle | 33% | 348.70 | 269 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 2.12 | 7 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0003198 | Biological process | epithelial to mesenchymal transition involved in endocardial cushion formation |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0071773 | Biological process | cellular response to BMP stimulus |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0072014 | Biological process | proximal tubule development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0003181 | Biological process | atrioventricular valve morphogenesis |
GO_0003180 | Biological process | aortic valve morphogenesis |
GO_0003203 | Biological process | endocardial cushion morphogenesis |
GO_0072359 | Biological process | circulatory system development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0060317 | Biological process | cardiac epithelial to mesenchymal transition |
GO_0003208 | Biological process | cardiac ventricle morphogenesis |
GO_0014031 | Biological process | mesenchymal cell development |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0060766 | Biological process | negative regulation of androgen receptor signaling pathway |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0032835 | Biological process | glomerulus development |
GO_0003184 | Biological process | pulmonary valve morphogenesis |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_0035914 | Biological process | skeletal muscle cell differentiation |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0050683 | Molecular function | AF-1 domain binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | HEYL |
Protein name | Hairy/enhancer-of-split related with YRPW motif-like protein (hHeyL) (Class B basic helix-loop-helix protein 33) (bHLHb33) (Hairy-related transcription factor 3) (HRT-3) (hHRT3) |
Synonyms | BHLHB33 HRT3 |
Description | FUNCTION: Downstream effector of Notch signaling which may be required for cardiovascular development (By similarity). Transcriptional repressor which binds preferentially to the canonical E box sequence 5'-CACGTG-3' (By similarity). Represses transcription by the cardiac transcriptional activators GATA4 and GATA6. . |
Accessions | Q9NQ87 ENST00000372852.4 |